• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Surgery
    • View Item
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Surgery
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Differences in receipt of multimodality therapy by race,insurance status, and socioeconomic disadvantage in patientswith resected pancreatic cancer

    Thumbnail
    View/ Open
    Article (1.020Mb)

    Show full item record
    Author
    Hao, Scarlett; Mitsakos, Anastasios; Irish, William; Tuttle‐Newhall, Janet Elizabeth; Parikh, Alexander A.; Rebecca A., Snyder
    Abstract
    Background and Methods:Racial and socioeconomic disparities in receipt ofadjuvant chemotherapy affect patients with pancreatic cancer. However, differencesin receipt of neoadjuvant chemotherapy among patients undergoing resection arenot well‐understood. A retrospective cross‐sectional cohort of patients withresected AJCC Stage I/II pancreatic ductal adenocarcinoma was identified fromthe National Cancer Database (2014–2017). Outcomes included receipt ofneoadjuvant versus adjuvant chemotherapy, or receipt of either, defined asmultimodality therapy and were assessed by univariate and multivariate analysis.Results:Of 19 588 patients, 5098 (26%) received neoadjuvant chemotherapy, 9624(49.1%) received adjuvant chemotherapy only, and 4757 (24.3%) received nochemotherapy. On multivariable analysis, Black patients had lower odds ofneoadjuvant chemotherapy compared to White patients (OR: 0.80, 95% CI:0.67–0.97) but no differences in receipt of multimodality therapy (OR: 0.89, 95%CI: 0.77–1.03). Patients with Medicaid or no insurance, low educational attainment,or low median income had significantly lower odds of receiving neoadjuvantchemotherapy or multimodality therapy.Conclusions:Racial and socioeconomic disparities persist in receipt of neoadjuvantand multimodality therapy in patients with resected pancreatic adenocarcinoma.Discussion:Policy and interventional implementations are needed to bridge thecontinued socioeconomic and racial disparity gap in pancreatic cancer care.
    Description
    This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
    URI
    http://hdl.handle.net/10342/10979
    Subject
     healthcare disparity; multimodal treatment; neoadjuvant chemotherapy,; pancreas cancer; socioeconomic factors 
    Date
    2022-03-10
    Citation:
    APA:
    Hao, Scarlett, & Mitsakos, Anastasios, & Irish, William, & Tuttle‐Newhall, Janet Elizabeth, & Parikh, Alexander A., & Rebecca A., Snyder. (March 2022). Differences in receipt of multimodality therapy by race,insurance status, and socioeconomic disadvantage in patientswith resected pancreatic cancer. , (), - . Retrieved from http://hdl.handle.net/10342/10979

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Hao, Scarlett, and Mitsakos, Anastasios, and Irish, William, and Tuttle‐Newhall, Janet Elizabeth, and Parikh, Alexander A., and Rebecca A., Snyder. "Differences in receipt of multimodality therapy by race,insurance status, and socioeconomic disadvantage in patientswith resected pancreatic cancer". . . (), March 2022. February 02, 2023. http://hdl.handle.net/10342/10979.
    Chicago:
    Hao, Scarlett and Mitsakos, Anastasios and Irish, William and Tuttle‐Newhall, Janet Elizabeth and Parikh, Alexander A. and Rebecca A., Snyder, "Differences in receipt of multimodality therapy by race,insurance status, and socioeconomic disadvantage in patientswith resected pancreatic cancer," , no. (March 2022), http://hdl.handle.net/10342/10979 (accessed February 02, 2023).
    AMA:
    Hao, Scarlett, Mitsakos, Anastasios, Irish, William, Tuttle‐Newhall, Janet Elizabeth, Parikh, Alexander A., Rebecca A., Snyder. Differences in receipt of multimodality therapy by race,insurance status, and socioeconomic disadvantage in patientswith resected pancreatic cancer. . March 2022; (): . http://hdl.handle.net/10342/10979. Accessed February 02, 2023.
    Collections
    • Carolina Consortium Publication Agreements
    • Surgery

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback